I came across this thread just prior to starting the Master's in BIotechnology program and found it concerning at the time. Having just completed a Master's in Biotechnology I felt I should provide a counterpoint to the experience described above.
The program offers clear tracks for those students who require a structured curriculum. This includes a recently added management track. However, the biggest perk is the flexibility offered by the program. I was able to take courses within the engineering , neuroscience, and business department focusing solely on my areas of interest and not spending money on coursework to meet predetermined requirements. Though there are requirements outlined for graduation with an ScM or AM, Dr. Schell is extremely supportive and will approve almost any reasonable modifications to ensure you receive the educational experience you want from the program. I had a great PI and was able to quickly be engaged in a project which will be submitted for publication in the coming months.
For those students looking to go into industry, they have built strong connections with many of the leading companies an individuals in the biotech industry. They provide near weekly opportunities to network and build connections, particularly with companies within the northeast. The payed Co-op experiences are also a nice perk. Anyways, it is a great program particularly for students who interest may not fit the structure of typical masters curriculum.
I am glad I did not let the above comment sway my decision to apply to this program. Perhaps things have changed significantly since 2016. That being said, I do think there is a valid point. If you think you are going to pursue a PhD, apply to PhD programs. PhDs are typically funded and many will allow you to incorporate a masters, so there is no reason to spend money getting a masters before hand.
